Class-leading microRNA RT-qPCR Technology
MiRXES’ patented reverse transcription (RT)-quantitative polymerase chain reaction (qPCR) technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.
This platform has been independently validated to be more sensitive than other RT-qPCR technologies for microRNA quantification.
microRNA-specific forward and reverse real-time PCR primers confer further specificity and enable robust amplification.
Optimized RT and qPCR master mixes that enhance signal-to-noise ratio.
This ease of use enables even first time users to generate consistent results from technical and biological replicates.